Paris, France

Samuel Abbou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Institut Gustave Roussy, Orphelia Pharma. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel Abbou. Retrieved from https://idiyas.com/inventor/samuel-abbou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Samuel Abbou: Innovator in Pharmaceutical Solutions

Introduction

Samuel Abbou is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on oral suspensions.

Latest Patents

Samuel Abbou holds a patent for an oral suspension of temozolomide. This pharmaceutical liquid suspension comprises temozolomide or a salt thereof, at least one agent controlling the solid state of temozolomide in suspension, a pharmaceutically acceptable liquid vehicle, and optionally at least one acid in a quantity that ensures the pH of the composition is below 5. Additionally, a powder blend for reconstituting the suspension is provided. He has 1 patent to his name.

Career Highlights

Throughout his career, Samuel Abbou has worked with prominent organizations such as Orphelia Pharma and Institut Gustave Roussy. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Samuel has collaborated with talented individuals in his field, including Maxime Annereau and Jérémy Bastid. Their teamwork has contributed to the advancement of pharmaceutical research and development.

Conclusion

Samuel Abbou is a distinguished inventor whose work in pharmaceutical innovations has made a significant impact. His contributions continue to influence the industry and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…